One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
11don MSN
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...
A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...
News-Medical.Net on MSN
Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...
News Medical on MSN
Johns Hopkins Scientists Develop Targeted Therapy for T-Cell Lymphomas and Leukemias
Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...
One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...
Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in ...
Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...
According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results